In a randomized trial of 395 adults aged 65-84, capromorelin increased lean body mass at 6 months, with improvements in tandem walk and stair climb
predominantly, in the case of compounds with a passive diffusion mechanism (Garberg et al., 2005)
Professor Sikirics research contributions include: Initial isolation and characterization of BPC-157 from human gastric secretions Extensive investigations of gastroprotective and tissue healing mechanisms Pioneering studies on musculoskeletal tissue repair including tendon and muscle healing Research on cardiovascular protective effects and vascular injury healing Over 400 published papers examining BPC-157s pleiotropic effects across organ systems His work has established BPC-157 as one of the most comprehensively studied components in peptide-based regenerative research, though human clinical validation remains absent

In our Stamford practice, we: Review your orthopedic and medical history Evaluate concurrent therapies (PRP, stem cells, surgery, physical therapy) Choose dosing schedules tailored to your goals Monitor progress, side effects, and outcomes We also avoid peptides in certain situations (e.g., active cancer, pregnancy, uncontrolled autoimmune flares) unless carefully coordinated with the rest of your care team
Shao Z, Newman E
GLP-1 medications for weight loss (with and without diabetes) While GLP-1 medications were originally developed to treat type 2 diabetes, it has become clear that their effects on appetite regulation and satiety can lead to substantial weight loss even in people who do not have diabetes